Experimental evaluation of microplasmin - An alternative to vital dyes

Developments in Ophthalmology

Volumn 42, Issue , 2008, Pages 153-159

  Gandorfer, A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; MICROPLASMIN; PEPTIDE FRAGMENT; PLASMIN;

ANIMAL; DRUG EFFECT; DRUG SCREENING; METHODOLOGY; RETINA; REVIEW; VITRECTOMY; VITREOUS BODY;

ANIMALS; DRUG EVALUATION, PRECLINICAL; FIBRINOLYTIC AGENTS; PEPTIDE FRAGMENTS; PLASMIN; RETINA; VITRECTOMY; VITREOUS BODY;

EID: 49449096585     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000139004     Document Type: Review

References (31)

1. Trese M: Enzymatic-assisted vitrectomy. Eye 2002;16:365-368.
2. Bhisitkul RB: Anticipation for enzymatic vitreolysis. Br J Ophthalmol 2001;85:1-2.
3. Sebag J: Pharmacologic vitreolysis. Retina 1998;18:1-3.
4. Sebag J: Is pharmacologic vitreolysis brewing? Retina 2002;22:1-3.
5. Schwartz SD, Alexander R, Hiscott P, Gregor ZJ: Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology 1996;103:323-328.
6. Williams JG, Trese MT, Williams GA, Hartzer MK: Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001;108:1902-1905.
7. Hageman GS, Russell SR: Chondroitinase-mediated disinsertion of the primate vitreous body. Invest Ophthalmol Vis Sci 1994;35:1260.
8. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR: Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140:573-584.
9. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR: Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140:585-597.
10. Hikichi T, Kado M, Yoshida A: Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina 2000;20:195-198.
11. Tezel TH, Del Priore LV, Kaplan HJ: Posterior vitreous detachment with dispase. Retina 1998;18:7-15.
12. Oliveira LB, Tatebayashi M, Mahmoud TH, Blackmon SM, Wong F, McCuen BW 2nd: Dispase facilitates posterior vitreous detachment during vitrectomy in young pigs. Retina 2001;21:324-331.
13. Jorge R, Oyamaguchi EK, Cardillo JA, Gobbi A, Laicine EM, Haddad A: Intravitreal injection of dispase causes retinal hemorrhages in rabbit and human eyes. Curr Eye Res 2003;26:107-112.
14. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ: Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987;28:506-514.
15. Kohno T, Sorgente N, Goodnight R, Ryan SJ: Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci 1987;28:515-521.
16. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981;41:4629-4636.
17. Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA: Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993;111:849-854.
18. Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A: Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina 1999;19:55-58.
19. Hesse L, Nebeling B, Schroeder B, Heller G, Kroll P: Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res 2000;70:31-39.
20. Hesse L, Chofflet J, Kroll P: Tissue plasminogen activator as a biochemical adjuvant in vitrectomy for proliferative diabetic vitreoretinopathy. Ger J Ophthalmol 1995;4:323-327.
21. Le Mer Y, Korobelnik JF, Morel C, Ullern M, Berrod JP: TPA-assisted vitrectomy for proliferative diabetic retinopathy: results of a double-masked, multicenter trial. Retina 1999;19:378-382.
22. Men G, Peyman GA, Genaidy M, Kuo PC, Ghahramani F, Blake DA, Bezerra Y, Naaman G, Figueiredo E: The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment. Retina 2004;24:199-209.
23. Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ: Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology 1998;105:1617-1620.
24. Trese MT, Williams GA, Hartzer MK: A new approach to stage 3 macular holes. Ophthalmology 2000;107:1607-1611.
25. Gandorfer A, Putz E, Welge-Lussen U, Gruterich M, Ulbig M, Kampik A: Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol 2001;85:6-10.
26. Gandorfer A, Priglinger S, Schebitz K, Hoops J, Ulbig M, Ruckhofer J, Grabner G, Kampik A: Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol 2002;133:156-159.
27. Li X, Shi X, Fan J: Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol 2002;240:56-62.
28. Gandorfer A, Ulbig M, Kampik A: Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye 2002;16:95-97.
29. Nagai N, Demarsin E, Van Hoef B, Wouters S, Cingolani D, Laroche Y, Collen D: Recombinant human microplasmin: production and potential therapeutic properties. J Thromb Haemost 2003;1:307-313.
30. Gandorfer A, Rohleder M, Sethi C, Eckle D, Welge-Lussen U, Kampik A, Luthert P, Charteris D: Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004;45:641-647.
31. Sakuma T, Tanaka M, Mizota A, Inoue J, Pakola S: Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci 2005;46:3295-3299.